SignatureFD’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
Other funds holding TVTX
SignatureFD's TVTX Position: Q3 2026 in Review
SignatureFD increased its Travere Therapeutics (TVTX) stake by 5.2% in Q3 2026, buying an estimated $4.15K and bringing the position to 1,365 shares worth $80.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1674.
SignatureFD first reported a position in TVTX in Q2 2019 and has held it in 18 quarters since. 341 funds tracked by Wall St. Rank hold TVTX as of Q3 2026.
- SignatureFD held 1,365 shares of Travere Therapeutics worth $80.4K as of Q3 2026.
- SignatureFD bought 68 Travere Therapeutics shares in Q3 2026, an estimated $4.15K.
- Travere Therapeutics made up ﹤0.01% of SignatureFD's portfolio in Q3 2026, its #1674 holding.
- SignatureFD first reported a position in Travere Therapeutics in Q2 2019 and has held it in 18 quarters since.
- 341 funds tracked by Wall St. Rank held Travere Therapeutics as of Q3 2026.
Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.